SkinHealth Systems Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
34.5%projected annual EPS growth
Analyst Coverage
6analysts covering
FY Revenue (est.)
$290.5Mnext fiscal year
FY EPS (est.)
$0.11next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 5 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Net Sales Quarterly64.9MTarget: 280000000 to 295000000
Adjusted EBITDA Quarterly8.5MTarget: 35000000 to 45000000
Active Installed Base Quarterly36.4KTarget: Continued global expansion
Delivery Systems Placed Quarterly746.0Target: Stabilization and recovery
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Stock price below $1.00 for 30 consecutive business daysAction: Regain compliance by November 4, 2026, potentially through a reverse stock split or organic price recovery.
- Capital Equipment Demand and Device PlacementsTrigger: Placements falling below 700 units per quarterAction: Re-evaluate sales execution, provider economics, and commercial strategies under the new clinical focus.
- Consumables Revenue and Utilization RatesTrigger: Consumables revenue dropping below $45 million per quarterAction: Enhance provider engagement, launch new booster innovations, and drive higher treatment utilization.
Research as of 20 Jun 2026